abstract |
Use of a composition comprising a Bacillus coagulans bacterium or extracellular product thereof in a pharmaceutically acceptable carrier for the manufacture of a medicament for treating bacterial, yeast, fungal or viral infection, wherein the medicament is suitable for topical application to skin or a mucous membrane of a mammal, and wherein the carrier is in the form of an emulsion, cream, lotion, gel, oil, ointment, suspension, aerosol spray, powder, aerosol powder, or semi-solid formulation. |